(MOVE) Movano - Ratings and Ratios

Movano Inc. (NASDAQ:MOVE) is a health technology company focused on developing innovative solutions at the intersection of medical-grade accuracy and consumer-friendly design. Its flagship product, the Evie Ring, is a wearable device tailored for women, offering a comprehensive suite of health and wellness metrics. These include resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, and menstrual cycle tracking. The device also monitors physical activity (steps, active minutes, calories burned), sleep patterns (stages and duration), and mood tracking, providing a holistic view of a users health. Movano is also developing advanced System-on-a-Chip (SoC) solutions for blood pressure monitoring and continuous glucose monitoring (CGM) systems, aiming to enhance accuracy and accessibility in chronic disease management.

Formerly known as Maestro Sensors Inc., the company rebranded as Movano Inc. in August 2018. Headquartered in Pleasanton, California, Movano Inc. was incorporated in 2018 and has since focused on bridging the gap between clinical-grade healthcare solutions and consumer-facing wearable technology. The companys products are designed to empower users with actionable health insights while addressing the growing demand for personalized and non-invasive health monitoring tools.

Ticker Symbol: MOVE
Exchange: NASDAQ
Type: common stock
Country Origin: United States
GICS Sub Industry: Technology Hardware, Storage & Peripherals

Average Volume 20d: 13505
Last Price: 3.56
SMA 20: 4.68
SMA 50: 5.13
SMA 200: 5.14
ATR: 0.32

Market Cap: 27.72M USD
P/E: 0.00
P/E Forward: 0.00
P/B: 3.16
P/S: 35.59
RoE: None

3-Month Forecast: - Technical Outlook: The stock is currently trading below its 20-day, 50-day, and 200-day moving averages, indicating bearish momentum. The ATR of 0.32 suggests low volatility, but the gap between the last price (3.56) and the SMA 20 (4.68) signals potential downside risk. - Fundamental Outlook: With a market cap of $27.72M and a P/S ratio of 35.59, the stock is trading at a premium relative to its peers. The lack of earnings (P/E: 0.00) and forward P/E (0.00) highlights the speculative nature of the investment, driven by growth expectations rather than current profitability. - Overall: Expect sideways to downward movement in the near term, with support levels likely testing the stocks resilience. Investors should monitor for potential catalysts, such as product launches or partnerships, that could drive upward momentum.